Specialties
General MSK
Specialties
Orthopaedics
51 results found in 2ms
ChondroFiller Injection Evidence Patients Should WeighChondroFiller Injection Evidence Patients Should Weigh
Injected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.Injected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.
ChondroFiller injection versus cartilage surgeryChondroFiller injection versus cartilage surgery
ChondroFiller injection achieves 30 IKDC improvement with 3–8% reoperation and 0% complications; microfracture carries 41% reoperation rates with declining long-term outcomes; ACI/MACI matches functional gains but brings 17% complications and 37% reoperation.ChondroFiller injection achieves 30 IKDC improvement with 3–8% reoperation and 0% complications; microfracture carries 41% reoperation rates with declining long-term outcomes; ACI/MACI matches functional gains but brings 17% complications and 37% reoperation.
Who qualifies for ChondroFiller Liquid Cartilage injectionWho qualifies for ChondroFiller Liquid Cartilage injection
ChondroFiller is an outpatient ultrasound-guided injection—not surgery—of acellular collagen that recruits the patient's own progenitor cells to regenerate cartilage damage, without upper age or defect-size limits.ChondroFiller is an outpatient ultrasound-guided injection—not surgery—of acellular collagen that recruits the patient's own progenitor cells to regenerate cartilage damage, without upper age or defect-size limits.
Who qualifies for a ChondroFiller injectionWho qualifies for a ChondroFiller injection
ChondroFiller targets ICRS Grade III–IV cartilage damage, where more than half the cartilage is lost or bone is exposed. Delivered as an ultrasound-guided outpatient injection, the collagen scaffold recruits the patient's own progenitor cells to initiate repair.ChondroFiller targets ICRS Grade III–IV cartilage damage, where more than half the cartilage is lost or bone is exposed. Delivered as an ultrasound-guided outpatient injection, the collagen scaffold recruits the patient's own progenitor cells to initiate repair.
ChondroFiller Injection Specialists in the UKChondroFiller Injection Specialists in the UK
Across 19,000+ treated cases worldwide, ChondroFiller has a complication rate of 0.06%; 70–85% of patients with focal cartilage defects achieve meaningful symptom relief over 3–5 years through a collagen scaffold that recruits the patient's own repair cells.Across 19,000+ treated cases worldwide, ChondroFiller has a complication rate of 0.06%; 70–85% of patients with focal cartilage defects achieve meaningful symptom relief over 3–5 years through a collagen scaffold that recruits the patient's own repair cells.
How long ChondroFiller results lastHow long ChondroFiller results last
ChondroFiller's collagen scaffold biodegrades within 6–24 months, yet provides lasting clinical benefit by recruiting the patient's own cells to form repair tissue; 70–85% of well-selected patients maintain meaningful symptom relief at three to five years.ChondroFiller's collagen scaffold biodegrades within 6–24 months, yet provides lasting clinical benefit by recruiting the patient's own cells to form repair tissue; 70–85% of well-selected patients maintain meaningful symptom relief at three to five years.
Which Specialist Treats a TFL StrainWhich Specialist Treats a TFL Strain
The tensor fasciae latae, small but carrying mechanical load out of proportion to its bulk, produces outer-hip pain; most cases respond to physiotherapy, though persistent strains warrant sports medicine assessment.The tensor fasciae latae, small but carrying mechanical load out of proportion to its bulk, produces outer-hip pain; most cases respond to physiotherapy, though persistent strains warrant sports medicine assessment.
What the ChondroFiller evidence actually showsWhat the ChondroFiller evidence actually shows
ChondroFiller, a collagen scaffold, increases knee function scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.ChondroFiller, a collagen scaffold, increases knee function scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.
ChondroFiller injection recovery timelineChondroFiller injection recovery timeline
ChondroFiller is an outpatient collagen scaffold injection that recruits the patient's own stem cells to repair cartilage; most people notice improvement within 6–12 weeks, though complete tissue replacement takes one to two years.ChondroFiller is an outpatient collagen scaffold injection that recruits the patient's own stem cells to repair cartilage; most people notice improvement within 6–12 weeks, though complete tissue replacement takes one to two years.
TFL Strain and Choosing the Right SpecialistTFL Strain and Choosing the Right Specialist
TFL strain ranges from acute tears to chronic overuse; clinical markers—weight-bearing ability, bruising extent, and palpable gap—grade the injury, and the grade determines whether physiotherapy or physician assessment is required first.TFL strain ranges from acute tears to chronic overuse; clinical markers—weight-bearing ability, bruising extent, and palpable gap—grade the injury, and the grade determines whether physiotherapy or physician assessment is required first.
51 results found in 2ms